OraSure Technologies reported $70.39M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Agilent USD 282.7M 358K Dec/2025
AngioDynamics USD 41.57M 127K Sep/2025
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Bio Techne USD 156.45M 703K Mar/2026
Bio-Rad Laboratories USD 26.99M 18K Dec/2025
Bruker USD 152.22M 282K Mar/2026
Charles River Laboratories USD 48.17M 1.05M Mar/2026
Danaher USD 707.7M 800K Mar/2026
Dentsply International USD 200.3M 700K Mar/2026
Dexcom USD 385.9M 1.1M Mar/2026
Illumina USD 151.91M 893K Mar/2026
Integra LifeSciences USD 77.82M 69K Mar/2026
Intuitive Surgical USD 355.17M 674K Mar/2026
IQVIA Holdings USD 166.9M 2.7M Mar/2026
Mesa Laboratories USD 349.53M 3.53M Sep/2024
Mettler Toledo International USD 20.25M 179.94K Mar/2026
Myriad Genetics USD 93.5M 400K Dec/2025
OraSure Technologies USD 70.39M 1.87M Dec/2025
Quidel USD 67.9M 0 Dec/2025
Repligen USD 56.4M 74K Mar/2026
Revvity USD 111.8M 1.57M Mar/2026
STAAR Surgical USD 49.78M 377K Mar/2026
Thermo Fisher Scientific USD 371.62M 4.09M Mar/2026
Trinity Biotech USD 385.2M 382.82M Jun/2025
Waters USD 98.17M 89K Mar/2026